The Relationship Between CYP2C19 Polymorphisms and Ischaemic and Bleeding Outcomes in Stable Outpatients: The CHARISMA Genetics Study

Study Questions:

What is the impact of CYP2C19 polymorphisms on ischemic and bleeding events?